FDA Inspection 1069938 — Lilly del Caribe, Inc

Lilly del Caribe, Inc — FEI 2619243

The FDA completed an inspection of Lilly del Caribe, Inc on September 21, 2018 in Carolina, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 21, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Carolina, PR (United States)